MedPath

INJECTABLE-PLATELET RICH FIBRIN AND HYALURONIC ACID GEL ON IMPLANT STABILITY AND CRESTAL BONE LEVEL IN IMPLANTS PLACED USING OSSEODENSIFICATION TECHNIQUE.

Not Applicable
Conditions
Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge
Registration Number
CTRI/2023/06/053389
Lead Sponsor
DR MALOTHU DURGA PRASAD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Individuals with an age group of 30-50 years of either gender.

2. Individuals in need of implant supported tooth

replacement.

3. Presence of adequate (minimum 1mm) keratinized

mucosa in the edentulous site.

4. Apparently healthy individuals.

5. Individuals with bone density classified as D2 and

D3 type of bone.

6. Subjects who are willing to give informed consent.

Exclusion Criteria

1. Individuals with parafunctional habits.

2. Pregnant and lactating women.

3. Subjects who are under medication which effects

bone metabolism.

4. Any form of tobacco users.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath